4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0000899243-21-031720
Options or other derivatives
- Senior VP, Chief Pharma Dev. acquired 35,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Waltermire Robert E. Senior VP, Chief Pharma Dev. | 2021-08-02 | Grant or award · Call Option | +35,000 | 35,000 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…